ArticleCancers2022

CSA Antisense Targeting Enhances Anticancer Drug Sensitivity in Breast Cancer Cells, including the Triple-Negative Subtype.

Silvia Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.